TScan Therapeutics (TCRX) Total Non-Current Liabilities (2020 - 2025)
TScan Therapeutics (TCRX) posted Total Non-Current Liabilities of $117.93 million for Q3 2025, down 0.7% from $118.79 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
At the end of FY2024, TScan Therapeutics' Total Non-Current Liabilities came in at $130.01 million.
- Annual Total Non-Current Liabilities shows a four-year compound annual growth rate of 9.0% (FY2020 to FY2024).
- In prior years, TScan Therapeutics' Total Non-Current Liabilities was $99.61 million in FY2022 (+265.8%), $27.23 million in FY2021 (-70.4%) and $91.96 million in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Total Non-Current Liabilities since Q1 2023.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2023, with growth of 511.1%; the weakest was Q2 2022, with a decline of 89.1%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $121.73 million (Q2 2025), $122.38 million (Q1 2025) and $130.01 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | TScan Therapeutics | 40.28 Mn | 40.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 117.93 Mn |
| Jun 30, 2025 | 121.73 Mn |
| Mar 31, 2025 | 122.38 Mn |
| Dec 31, 2024 | 130.01 Mn |
| Sep 30, 2024 | 118.79 Mn |
| Sep 30, 2023 | 122.41 Mn |
| Jun 30, 2023 | 126.29 Mn |
| Mar 31, 2023 | 95.52 Mn |
| Dec 31, 2022 | 99.61 Mn |
| Sep 30, 2022 | 48.70 Mn |
| Jun 30, 2022 | 20.67 Mn |
| Mar 31, 2022 | 22.41 Mn |
| Dec 31, 2021 | 27.23 Mn |
| Sep 30, 2021 | 30.58 Mn |
| Jun 30, 2021 | 189.80 Mn |
| Dec 31, 2020 | 91.96 Mn |
API Access
TScan Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();